• 1. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 2. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615
• 3. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 4. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 5. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Alkyl aryl ethers
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ethers Alkyl aryl ethers

Introduction to (3-methoxy-4-pyridyl)boronic acid;hydrate (CAS No. 1072952-50-1)

(3-methoxy-4-pyridyl)boronic acid;hydrate (CAS No. 1072952-50-1) is a versatile compound that has gained significant attention in the fields of organic synthesis, medicinal chemistry, and materials science. This boronic acid derivative is characterized by its unique structure, which combines a pyridine ring with a methoxy substituent and a boronic acid functional group. The presence of these functional groups endows the compound with a wide range of reactivity and potential applications.

The pyridine ring is a fundamental building block in organic chemistry, known for its aromaticity and electron-withdrawing properties. The methoxy substituent at the 3-position enhances the compound's solubility and stability, making it more suitable for various synthetic transformations. The boronic acid group, on the other hand, is highly reactive and can participate in a variety of chemical reactions, including Suzuki-Miyaura coupling, which is widely used in the synthesis of complex organic molecules and pharmaceuticals.

Recent research has highlighted the importance of (3-methoxy-4-pyridyl)boronic acid;hydrate in the development of new materials and pharmaceuticals. For instance, a study published in the Journal of Medicinal Chemistry demonstrated that this compound can be used as an intermediate in the synthesis of novel antiviral agents. The researchers found that the boronic acid group facilitated the formation of key intermediates, leading to the successful synthesis of compounds with potent antiviral activity against several strains of viruses.

In another study, published in Organic Letters, scientists explored the use of (3-methoxy-4-pyridyl)boronic acid;hydrate in the synthesis of metal-organic frameworks (MOFs). MOFs are highly porous materials with applications in gas storage, catalysis, and drug delivery. The researchers discovered that the pyridine ring and methoxy substituent in this compound enhanced its coordination ability with metal ions, resulting in MOFs with improved stability and performance.

The versatility of (3-methoxy-4-pyridyl)boronic acid;hydrate extends beyond its use as a synthetic intermediate. It has also been investigated for its potential as a ligand in coordination chemistry. A recent publication in Inorganic Chemistry reported that this compound can form stable complexes with transition metals, which could be useful in catalytic processes and as precursors for advanced materials.

In the context of medicinal chemistry, (3-methoxy-4-pyridyl)boronic acid;hydrate has shown promise as a scaffold for drug discovery. Its ability to undergo selective functionalization makes it an attractive starting point for the development of new therapeutic agents. For example, researchers at a leading pharmaceutical company have used this compound to synthesize a series of compounds with potential anti-cancer activity. Preliminary studies have indicated that these compounds exhibit selective cytotoxicity against cancer cells while showing minimal toxicity to normal cells.

The physical properties of (3-methoxy-4-pyridyl)boronic acid;hydrate are also noteworthy. It is typically provided as a white crystalline solid with good solubility in polar solvents such as water and methanol. This solubility profile makes it easy to handle and use in various chemical reactions. Additionally, its stability under mild conditions ensures that it can be stored and transported without significant degradation.

Safety considerations are an important aspect when working with any chemical compound. While (3-methoxy-4-pyridyl)boronic acid;hydrate is generally considered safe under normal laboratory conditions, appropriate precautions should be taken to ensure safe handling and disposal. It is recommended to use personal protective equipment (PPE) such as gloves and goggles when handling this compound to prevent skin contact and inhalation.

In conclusion, (3-methoxy-4-pyridyl)boronic acid;hydrate (CAS No. 1072952-50-1) is a valuable compound with diverse applications in organic synthesis, medicinal chemistry, materials science, and coordination chemistry. Its unique structure and reactivity make it an essential tool for researchers working on the development of new materials and pharmaceuticals. As ongoing research continues to uncover new uses for this compound, its importance in various scientific fields is likely to grow even further.

• 1029438-34-3(4-(Pyridin-3-yloxy)phenylboronic acid)
• 1093231-09-4(8-Methoxyquinoline-7-boronic acid)
• 1072952-48-7((2-Bromo-5-methoxypyridin-4-yl)boronic acid)
• 355004-67-0((4-Methoxypyridin-3-yl)boronic acid)
• 1310384-04-3((3-Ethoxypyridin-4-yl)boronic acid)
• 1031438-93-3((2,3-dimethoxypyridin-4-yl)boronic acid)
• 1256355-26-6((4-methoxy-3-pyridyl)boronic acid;hydrate)
• 1008506-24-8(3-Methoxypyridine-4-boronic acid)
• 850991-69-4((5-methoxy-3-pyridinyl)boronic acid)
• 1247667-11-3(5-Methoxy-2-methyl-4-pyridinyl-boronic Acid)